These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
518 related items for PubMed ID: 24060192
1. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism. Pedowska-Włoszek J, Kostrubiec M, Kurnicka K, Ciurzynski M, Palczewski P, Pruszczyk P. Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192 [Abstract] [Full Text] [Related]
14. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort. Miller L, Chartrand S, Koenig M, Goulet JR, Rich É, Chin AS, Chartrand-Lefebvre C, Abrahamowicz M, Senécal JL, Grodzicky T. Scand J Rheumatol; 2014 Oct; 43(4):314-23. PubMed ID: 25089008 [Abstract] [Full Text] [Related]
15. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A, Mueller C, Nowak RM, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng LL, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Hartmann O, Morgenthaler NG, Anker SD. J Am Coll Cardiol; 2011 Aug 30; 58(10):1057-67. PubMed ID: 21867843 [Abstract] [Full Text] [Related]
16. Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study. Fraty M, Velho G, Gand E, Fumeron F, Ragot S, Sosner P, Mohammedi K, Gellen B, Saulnier PJ, Halimi JM, Montaigne D, Ducrocq G, Rehman M, Marre M, Roussel R, Hadjadj S, SURDIAGENE Study Group. Diabetologia; 2018 Dec 30; 61(12):2643-2653. PubMed ID: 30232509 [Abstract] [Full Text] [Related]
17. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts? Kaiser R, Abdul-Khaliq H, Wilkens H, Herrmann E, Raedle-Hurst TM. Eur J Heart Fail; 2014 Oct 30; 16(10):1082-8. PubMed ID: 25201135 [Abstract] [Full Text] [Related]
18. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study. Funke-Kaiser A, Mann K, Colquhoun D, Zeller T, Hunt D, Simes J, Sullivan D, Sydow K, West M, White H, Blankenberg S, Tonkin AM, LIPID Study Investigators. Int J Cardiol; 2014 Mar 15; 172(2):411-8. PubMed ID: 24508492 [Abstract] [Full Text] [Related]